{"id":6388,"date":"2018-07-23T07:16:11","date_gmt":"2018-07-23T07:16:11","guid":{"rendered":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/"},"modified":"2018-07-23T07:16:11","modified_gmt":"2018-07-23T07:16:11","slug":"agarforandringar-i-scandinavian-real-heart-ab","status":"publish","type":"mfn_news","link":"https:\/\/realheart.se\/sv\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/","title":{"rendered":"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB"},"content":{"rendered":"<p><span>Azad Najar, VD och grundare av Scandinavian Real Heart AB (Real Heart), noterat p\u00e5 Spotlight har via sitt bolag Najar Medical and Invention AB \u00f6verl\u00e5tit 282 096 aktier i Real Heart till sin bror, Bilend Najar. Aktieposten motsvarar 2 procent av antalet utest\u00e5ende aktier i Real Heart.<\/span><\/p>\n<p><span>\u201dMin bror Bilend var delaktig i utvecklingen av hj\u00e4rtpumpen under \u00e5ren 2008-2012 med framtagning av flera prototyper utan ekonomisk ers\u00e4ttning. Vi har haft en l\u00f6s \u00f6verenskommelse om att Bilend skulle f\u00e5 f\u00f6rv\u00e4rva aktier av mig sedan tidigare, men den har inte materialiserats f\u00f6rr\u00e4n nu\u201d,\u00a0<span>s\u00e4ger Azad Najar.<\/span><\/span><\/p>\n<p><span>Bilend Najar innehar sedan tidigare 155\u00a0985 aktier i Real Heart, motsvarande 1,1 procent av kapital och r\u00f6ster.<\/span><\/p>\n<p><span>Azad Najar har d\u00e4rut\u00f6ver via sitt bolag Najar Medical and Invention AB avyttrat 140 000 aktier i Real Heart till Kjell Sk\u00f6ldberg \u00e4gare till Eskilstuna Hem AB (\u201dEskilstunahem\u201d), som sedan tidigare innehar ca 4,96 procent av aktier och r\u00f6ster i Real Heart. <\/span><\/p>\n<p><span>\u201cJag beh\u00f6ver frig\u00f6ra lite kapital f\u00f6r mitt andra utvecklingsprojekt som sk\u00f6ts av eget team. Jag jobbar heltid i Real Heart och jobbar med en rabatterad ers\u00e4ttning. Eskilstunahem\/Kjell Sk\u00f6ldberg \u00e4r dessutom en engagerad insynsperson i Real Heart, finansiellt stark och l\u00e5ngsiktig aktie\u00e4gare, s\u00e5 det k\u00e4nns positivt att han vill \u00f6ka sitt innehav&#34;, f\u00f6rklarar Azad Najar.<\/span><\/p>\n<p><span>Genom ovanst\u00e5ende transaktioner minskar Azad Najars aktieinnehav i Real Heart fr\u00e5n 3\u00a0600 564 aktier till 3\u00a0178 468 aktier motsvarande fr\u00e5n 25,5 procent till 22,5 procent.<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><strong>F\u00f6r ytterligare information kontakta:<\/strong><\/span><\/p>\n<p><span>Azad Najar, VD <\/span><\/p>\n<p><span>Tel: +46(0)736-673\u00a0463<\/span><\/p>\n<p><span>E-post:\u00a0<\/span><a href=\"mailto:azad.najar@realheart.se\" rel=\"nofollow\"><span>azad.najar@realheart.se<\/span><\/a>\u00a0<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><em><span>Om Scandinavian Real Heart AB \u2013 Endast cirka 5 000 hj\u00e4rttransplantationer sker \u00e5rligen i hela v\u00e4rlden och tillg\u00e5ngen p\u00e5 donerade hj\u00e4rtan \u00e4r mycket begr\u00e4nsad. Behovet \u00e4r stort och patienter med hj\u00e4rtsvikt avlider i v\u00e4ntan p\u00e5 ett nytt hj\u00e4rta. Scandinavian Real Heart AB utvecklar en hj\u00e4rtpump (TAH) som efterliknar kroppens naturliga cirkulation och som ska kunna anv\u00e4ndas som en \u00f6verg\u00e5ngsl\u00f6sning f\u00f6r patienter som v\u00e4ntar p\u00e5 en hj\u00e4rttransplantation.<\/span><\/em><\/p>\n<\/div>\n<script>\n                Array.prototype.slice.call(document.querySelectorAll(\".mfn-footer.mfn-attachment\")).forEach(function (el) { el.remove() });\n            <\/script>\n        <div class=\"mfn-attachments-container\"><div class=\"mfn-attachment\"><a class=\"mfn-attachment-link\" href=\"https:\/\/storage.mfn.se\/proxy\/se-pressmeddelande.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2579909%2F882103.pdf\"><span class=\"mfn-attachment-icon\"><img decoding=\"async\" src=\"https:\/\/storage.mfn.se\/proxy\/se-pressmeddelande.pdf?url=https%3A%2F%2Fmb.cision.com%2FMain%2F12118%2F2579909%2F882103.pdf&type=jpg\"><\/span>Se Pressmeddelande<\/a><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Azad Najar, VD och grundare av Scandinavian Real Heart AB (Real Heart), noterat p\u00e5 Spotlight har via sitt bolag Najar Medical and Invention AB \u00f6verl\u00e5tit 282 096 aktier i Real Heart till sin bror, Bilend Najar. Aktieposten motsvarar 2 procent av antalet utest\u00e5ende aktier i Real Heart. \u201dMin bror Bilend var delaktig i utvecklingen av&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-6388","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-ci-staff","mfn-news-tag-mfn-lang-sv"],"acf":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart\" \/>\n<meta property=\"og:description\" content=\"Azad Najar, VD och grundare av Scandinavian Real Heart AB (Real Heart), noterat p\u00e5 Spotlight har via sitt bolag Najar Medical and Invention AB \u00f6verl\u00e5tit 282 096 aktier i Real Heart till sin bror, Bilend Najar. Aktieposten motsvarar 2 procent av antalet utest\u00e5ende aktier i Real Heart. \u201dMin bror Bilend var delaktig i utvecklingen av...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/\" \/>\n<meta property=\"og:site_name\" content=\"Realheart\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/agarforandringar-i-scandinavian-real-heart-ab\\\/\",\"url\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/agarforandringar-i-scandinavian-real-heart-ab\\\/\",\"name\":\"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\"},\"datePublished\":\"2018-07-23T07:16:11+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/agarforandringar-i-scandinavian-real-heart-ab\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/agarforandringar-i-scandinavian-real-heart-ab\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/agarforandringar-i-scandinavian-real-heart-ab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/realheart.se\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/realheart.se\\\/#website\",\"url\":\"https:\\\/\\\/realheart.se\\\/\",\"name\":\"Realheart\",\"description\":\"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/realheart.se\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/","og_locale":"sv_SE","og_type":"article","og_title":"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart","og_description":"Azad Najar, VD och grundare av Scandinavian Real Heart AB (Real Heart), noterat p\u00e5 Spotlight har via sitt bolag Najar Medical and Invention AB \u00f6verl\u00e5tit 282 096 aktier i Real Heart till sin bror, Bilend Najar. Aktieposten motsvarar 2 procent av antalet utest\u00e5ende aktier i Real Heart. \u201dMin bror Bilend var delaktig i utvecklingen av...","og_url":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/","og_site_name":"Realheart","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/","url":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/","name":"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB - Realheart","isPartOf":{"@id":"https:\/\/realheart.se\/#website"},"datePublished":"2018-07-23T07:16:11+00:00","breadcrumb":{"@id":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/realheart.se\/mfn_news\/agarforandringar-i-scandinavian-real-heart-ab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"MFN News Items","item":"https:\/\/realheart.se\/mfn_news\/"},{"@type":"ListItem","position":2,"name":"\u00c4garf\u00f6r\u00e4ndringar i Scandinavian Real Heart AB"}]},{"@type":"WebSite","@id":"https:\/\/realheart.se\/#website","url":"https:\/\/realheart.se\/","name":"Realheart","description":"\u00c4r ett medicintekniskt f\u00f6retag som utvecklar ett artificiellt hj\u00e4rta som ska r\u00e4dda liv p\u00e5 sv\u00e5rt hj\u00e4rtsjuka personer som st\u00e5r i transplantationsk\u00f6.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/realheart.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news\/6388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/realheart.se\/sv\/wp-json\/wp\/v2\/media?parent=6388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}